US Broker Ratings

Doximity, Inc. (DOCS) Stock Analysis: A Look at Its 57% Potential Upside and Strong Buy Sentiment

Doximity, Inc. (NYSE: DOCS) is capturing investor attention with a notable 57.32% potential upside, according to recent analyst ratings. As a leading digital platform for medical professionals, Doximity operates within..

Tempus AI, Inc. (TEM) Stock Analysis: Uncovering the Potential 38.91% Upside with Cutting-Edge Healthcare Technology

Tempus AI, Inc. (NASDAQ: TEM), a burgeoning player in the healthcare information services industry, is making waves with its innovative technology platform that aims to revolutionize how healthcare providers interact..

Corcept Therapeutics (CORT) Stock Analysis: Exploring a 46% Potential Upside for Investors

Corcept Therapeutics Incorporated (NASDAQ: CORT) has been making waves in the biotechnology sector, captivating investor interest with its robust focus on developing treatments for severe endocrinologic, oncologic, metabolic, and neurologic..

Illumina, Inc. (ILMN) Stock Analysis: Unveiling Growth Potential with a Promising Upside

Illumina, Inc. (NASDAQ: ILMN) stands as a beacon in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $19.43 billion, Illumina is a formidable..

Bio-Techne Corp (TECH) Stock Analysis: Exploring a 33% Potential Upside in the Biotech Sector

Bio-Techne Corp (NASDAQ: TECH), a stalwart in the biotechnology sector, has captured investor attention with a compelling potential upside of 33.37%. Headquartered in Minneapolis, Minnesota, Bio-Techne develops, manufactures, and sells..

Solventum Corporation (SOLV) Stock Analysis: Unveiling a 23.56% Potential Upside in the Healthcare Sector

Solventum Corporation (SOLV), a prominent player in the healthcare industry, offers a diverse range of medical instruments and supplies. With a current market capitalization of $11.89 billion, SOLV has captured..

Henry Schein, Inc. (HSIC) Stock Analysis: Exploring a 16.35% Potential Upside in Healthcare Distribution

Henry Schein, Inc. (NASDAQ: HSIC), a prominent player in the healthcare sector, stands at the intersection of medical distribution and value-added services. With a significant market capitalization of $8.9 billion,..

Chemed Corp (CHE) Stock Analysis: Investor Outlook on Healthcare’s Resilient Performer

Chemed Corporation (NYSE: CHE), a notable player in the healthcare sector, continues to capture investor attention with its robust operational segments and strategic market positioning. With a market cap of..

Novartis AG (NVS) Stock Analysis: Navigating a Steady Path with a 5.36% Potential Upside

As one of the titans in the healthcare sector, Novartis AG (NVS) continues to command attention from both seasoned and new investors. Headquartered in Basel, Switzerland, this pharmaceutical giant is..

Johnson & Johnson (JNJ) Stock Analysis: Evaluating a 10.95% Potential Upside for Investors

Johnson & Johnson (NYSE: JNJ), a titan in the healthcare sector, continues to capture the attention of investors worldwide with its robust market cap of $547.64 billion and a significant..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Unveiling a 31.83% Potential Upside

Investors seeking a foothold in the healthcare sector often look for companies that blend innovation with robust financial prospects. GE HealthCare Technologies Inc. (NYSE: GEHC), with its strategic positioning in..

BioNTech SE (BNTX) Stock Analysis: Navigating a 24% Potential Upside Amidst Biotech Challenges

BioNTech SE (NASDAQ: BNTX), renowned for its pioneering work in mRNA technology, particularly the development of the BNT162 vaccine for COVID-19, remains a compelling focus within the biotechnology sector. With..

Encompass Health Corporation (EHC): Investor Outlook with a Compelling 39.96% Upside Potential

Encompass Health Corporation (NYSE: EHC) stands as a formidable entity in the healthcare sector, specializing in providing inpatient rehabilitation services across the United States and Puerto Rico. With a robust..

Insulet Corporation (PODD) Investor Outlook: Exploring a 72% Potential Upside

Insulet Corporation (NASDAQ: PODD), a prominent player in the healthcare sector, specifically within the medical devices industry, is captivating investors’ attention with its cutting-edge insulin delivery systems. Headquartered in Acton,..

Revvity, Inc. (RVTY) Stock Analysis: Exploring a 31% Potential Upside with Strong Analyst Ratings

Investors eyeing opportunities in the healthcare sector may find Revvity, Inc. (NYSE: RVTY) an intriguing candidate. With a strong foothold in the diagnostics and research industry, Revvity is poised for..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Unlocking a 45% Upside Potential Amid Strong Buy Ratings

Neurocrine Biosciences, Inc. (NBIX) is making waves in the healthcare sector, especially among investors seeking opportunities in the specialty and generic drug manufacturing industry. With a current market capitalization of..

argenx SE (ARGX) Stock Analysis: Unveiling a 32.71% Potential Upside

argenx SE (NASDAQ: ARGX), a prominent player in the biotechnology sector, has captured the attention of investors with its promising therapies for autoimmune diseases. With a market capitalization of $48.76..

Sanofi (SNY) Stock Analysis: Exploring a 19.97% Upside Potential in the Healthcare Sector

Sanofi (SNY), a prominent player in the global healthcare sector, stands out for its diverse portfolio that spans immunology, oncology, and a range of vaccines. With a market capitalization exceeding..

Tenet Healthcare Corporation (THC) Stock Analysis: Exploring a 45.4% Potential Upside

Tenet Healthcare Corporation (NYSE: THC) is a pivotal player in the U.S. healthcare landscape, operating an extensive network of healthcare facilities. With a market capitalization of $15.84 billion, Tenet stands..

CVS Health Corporation (CVS): Investor Outlook Reveals 23.91% Potential Upside with Strong Buy Ratings

CVS Health Corporation (NYSE: CVS), a leader in the healthcare sector, specifically within the healthcare plans industry, presents a compelling investment opportunity with a market capitalization of $99.89 billion. As..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds